China Moves 30 Drugs OTC, Encourages Nonprescription Switches
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - China's State FDA assigned 30 drugs over-the-counter status in a notice issued Jan. 11, reflecting the agency's interest in expanding availability of nonprescription drugs to help reduce health care costs